BirchBioMed Inc. (BRBM)

BirchBioMed will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

BirchBioMed Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	-	3.24	0.66
Research & Development	-	0.22	0.19
Operating Expenses	-	3.46	0.85
Operating Income	-3.13	-3.46	-0.85
Interest Expense (Income)	0.01	0.01	0
Other Expense (Income)	1.09	1.08	0.04
Pretax Income	-4.24	-4.55	-0.89
Net Income	-4.24	-4.55	-0.89

Additional Metrics

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-2.13	-2.2	-0.79
Free Cash Flow Growth	-	-	-
EBITDA	-4.22	-4.54	-0.89
EBIT	-4.22	-4.54	-0.89